Fig 1.
CONSORT 2010 flow diagram.
Table 1.
Demographic characteristics.
Table 2.
VAS scores and complication registration.
Table 3.
Characteristics of the orofacial pain patient group.
Fig 2.
Differences in the cumulative, total intake of pain medication in milligram per day before and after MCS.
GABA, gamma-aminobutyric acid; NSAID, non-steroidal anti-inflammatory drug; MCS, motor cortex stimulation; SSNRI, selective serotonin and norepinephrine reuptake inhibitor.
Table 4.
Stimulation parameters, medication quantification scales and analgesic effects per patient.